Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Pharma Foods International Co's Net Margin % or its related term are showing as below:
TSE:2929'
s Net Margin % Range Over the Past 10 Years
Min: -2.19 Med: 4.22 Max: 8.22
Current: -2.19
TSE:2929's Net Margin % is ranked worse than 69.06% of 960
companies
in the Drug Manufacturers industry
Industry Median: 5.635
vs TSE:2929: -2.19
Pharma Foods International Co (TSE:2929) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Pharma Foods International Co Net Margin % Related Terms
Pharma Foods International Co Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Pharma Foods International Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharma Foods International Co Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Pharma Foods International Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Pharma Foods International Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharma Foods International Co (TSE:2929) has a Net Margin % of 0.40% as of Jan. 2026. Net margin is the ratio of total net income to net sales. View historical data on Pharma Foods International Co and its competitors. This is 91% below median its historical median of 4.22. According to the industry distribution chart, Pharma Foods International Co ranks #663 out of 960 companies in the Drug Manufacturers industry, placing it in the top 69.1%.
Is Pharma Foods International Co's Net Margin % too high?
Pharma Foods International Co's current Net Margin % of 0.40% is 91% below median its 10-year median of 4.22. The Drug Manufacturers industry median Net Margin % is 5.64. Pharma Foods International Co's value of 0.40% is 92.9% below this industry median. Based on the distribution chart, Pharma Foods International Co ranks #663 out of 960 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Pharma Foods International Co has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Pharma Foods International Co's Net Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Pharma Foods International Co ranks #663 out of 960 companies for Net Margin %. This places Pharma Foods International Co in the lower half of its industry. The industry median Net Margin % is 5.64. Pharma Foods International Co's value of 0.40% is 92.9% below this benchmark. While the company's 10-year median is 4.22 vs. the industry median of 5.64, Pharma Foods International Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.64, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pharma Foods International Co's current Net Margin % of 0.40% is 92.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Pharma Foods International Co and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharma Foods International Co's current Net Margin % is 0.40%, which is 91% below median its own 10-year median of 4.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma Foods International Co stock overvalued right now?
Based on GuruFocus' analysis, Pharma Foods International Co (TSE:2929) is currently considered Possible Value Trap. The stock's GF Value™ is 円1,051.63, compared to a current price of 円588.00 — trading 44.1% below its estimated fair value. The current Net Margin % is 0.40%, which is 91% below median its 10-year median of 4.22 and 92.9% below the Drug Manufacturers industry median of 5.64. Pharma Foods International Co's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Pharma Foods International Co (TSE:2929), the current Net Margin % is 0.40% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pharma Foods International Co (TSE:2929) Overvalued in 2026?
Based on GuruFocus' analysis, Pharma Foods International Co stock appears to be undervalued.
The current stock price of 円588.00 is trading 44.1% below its estimated GF Value™ of 円1,051.63.
GuruFocus considers Pharma Foods International Co to be Possible Value Trap.
Key valuation signals for TSE:2929:
Net Margin %: 0.40% (91% below median its 10-year median of 4.22)
GF Value™: 円1,051.63 vs. price of 円588.00 (44.1% below fair value)
Industry Position: 92.9% below the Drug Manufacturers median (#663 of 960)
No single metric tells the full story. See the TSE:2929 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pharma Foods International Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2929 has been successfully added to your 
